by David Cassak
Editor’s Note: The following article is excerpted from "Israel’s Device Community: Finding New Models as Medtech Matures," published in the October 2008 issue of IN VIVO.
Israel's Device Community: Opportunities and Challenges Ahead
This article is excerpted from "Israel's Device Community: Finding New Models as Medtech Matures," In Vivo, October 2008. (Article number 2008800161.)
More from Archive
More from Medtech Insight
• By
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
• By
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
• By
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.